Director/PDMR Dealing

June 25, 2021
PDF Version
RNS Number : 2249D
Renalytix PLC
25 June 2021
 

 

Renalytix plc 

 

("Renalytix" or the "Company")

 

Director/PDMR Dealing

 

The Company was informed that today, Fergus Fleming, Chief Technology Officer, completed the sale of 15,000 ordinary shares of 0.25 pence each ("Ordinary Shares") in the Company at a price of 1075 pence per share.

 

Following completion of the sale, Fergus Fleming is interested in  569,481 Ordinary Shares representing 0.79% of the current issued share capital of the Company.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name 

 

 

 

Fergus Fleming

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chief Technology Officer

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name 

 

 

Renalytix plc

b)

 

LEI

 

 

213800NTOH3FK3WER551

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of  £0.0025 each



Identification code

GB00BYWL4Y04

 

 


b)

 

Nature of the transaction

 

 

Sale of shares

c)

Currency

GBP

d)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

£10.75

15,000

 


 

 

 

 

e)

 

Aggregated information




- Aggregated volume

15,000



- Price

£161,250.00



f)

 

Date of the transaction

 

 

25 June 2021

g)

 

Place of the transaction

 

 

London Stock Exchange

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQELFLFQLLBBX